| pubmed-article:15870414 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:15870414 | lifeskim:mentions | umls-concept:C0008976 | lld:lifeskim |
| pubmed-article:15870414 | lifeskim:mentions | umls-concept:C0034656 | lld:lifeskim |
| pubmed-article:15870414 | lifeskim:mentions | umls-concept:C0155626 | lld:lifeskim |
| pubmed-article:15870414 | lifeskim:mentions | umls-concept:C0038257 | lld:lifeskim |
| pubmed-article:15870414 | lifeskim:mentions | umls-concept:C0247025 | lld:lifeskim |
| pubmed-article:15870414 | lifeskim:mentions | umls-concept:C0288672 | lld:lifeskim |
| pubmed-article:15870414 | pubmed:issue | 17 | lld:pubmed |
| pubmed-article:15870414 | pubmed:dateCreated | 2005-5-4 | lld:pubmed |
| pubmed-article:15870414 | pubmed:abstractText | Bare-metal stenting with abciximab pretreatment is currently considered a reasonable reperfusion strategy for acute ST-segment elevation myocardial infarction (STEMI). Sirolimus-eluting stents significantly reduce the need for target-vessel revascularization (TVR) vs bare-metal stents but substantially increase procedural costs. At current European list prices, the use of tirofiban instead of abciximab would absorb the difference in cost between stenting with sirolimus-eluting vs bare-metal stents. | lld:pubmed |
| pubmed-article:15870414 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15870414 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15870414 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15870414 | pubmed:language | eng | lld:pubmed |
| pubmed-article:15870414 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15870414 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:15870414 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15870414 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15870414 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15870414 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15870414 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15870414 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15870414 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15870414 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15870414 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15870414 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:15870414 | pubmed:month | May | lld:pubmed |
| pubmed-article:15870414 | pubmed:issn | 1538-3598 | lld:pubmed |
| pubmed-article:15870414 | pubmed:author | pubmed-author:BoersmaEricE | lld:pubmed |
| pubmed-article:15870414 | pubmed:author | pubmed-author:FerrariFabriz... | lld:pubmed |
| pubmed-article:15870414 | pubmed:author | pubmed-author:FerrariRobert... | lld:pubmed |
| pubmed-article:15870414 | pubmed:author | pubmed-author:ParrinelloGio... | lld:pubmed |
| pubmed-article:15870414 | pubmed:author | pubmed-author:McFaddenEugèn... | lld:pubmed |
| pubmed-article:15870414 | pubmed:author | pubmed-author:ValgimigliMar... | lld:pubmed |
| pubmed-article:15870414 | pubmed:author | pubmed-author:GuardigliGabr... | lld:pubmed |
| pubmed-article:15870414 | pubmed:author | pubmed-author:MalaguttiPatr... | lld:pubmed |
| pubmed-article:15870414 | pubmed:author | pubmed-author:CicchitelliGi... | lld:pubmed |
| pubmed-article:15870414 | pubmed:author | pubmed-author:PercocoGianfr... | lld:pubmed |
| pubmed-article:15870414 | pubmed:author | pubmed-author:BarbieriDario... | lld:pubmed |
| pubmed-article:15870414 | pubmed:author | pubmed-author:AnsaniLuciaL | lld:pubmed |
| pubmed-article:15870414 | pubmed:author | pubmed-author:BettiniAlessa... | lld:pubmed |
| pubmed-article:15870414 | pubmed:author | pubmed-author:CampoGianluca... | lld:pubmed |
| pubmed-article:15870414 | pubmed:author | pubmed-author:MerliniFabiaF | lld:pubmed |
| pubmed-article:15870414 | pubmed:author | pubmed-author:STRATEGY... | lld:pubmed |
| pubmed-article:15870414 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:15870414 | pubmed:day | 4 | lld:pubmed |
| pubmed-article:15870414 | pubmed:volume | 293 | lld:pubmed |
| pubmed-article:15870414 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:15870414 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:15870414 | pubmed:pagination | 2109-17 | lld:pubmed |
| pubmed-article:15870414 | pubmed:dateRevised | 2010-11-18 | lld:pubmed |
| pubmed-article:15870414 | pubmed:meshHeading | pubmed-meshheading:15870414... | lld:pubmed |
| pubmed-article:15870414 | pubmed:meshHeading | pubmed-meshheading:15870414... | lld:pubmed |
| pubmed-article:15870414 | pubmed:meshHeading | pubmed-meshheading:15870414... | lld:pubmed |
| pubmed-article:15870414 | pubmed:meshHeading | pubmed-meshheading:15870414... | lld:pubmed |
| pubmed-article:15870414 | pubmed:meshHeading | pubmed-meshheading:15870414... | lld:pubmed |
| pubmed-article:15870414 | pubmed:meshHeading | pubmed-meshheading:15870414... | lld:pubmed |
| pubmed-article:15870414 | pubmed:meshHeading | pubmed-meshheading:15870414... | lld:pubmed |
| pubmed-article:15870414 | pubmed:meshHeading | pubmed-meshheading:15870414... | lld:pubmed |
| pubmed-article:15870414 | pubmed:meshHeading | pubmed-meshheading:15870414... | lld:pubmed |
| pubmed-article:15870414 | pubmed:meshHeading | pubmed-meshheading:15870414... | lld:pubmed |
| pubmed-article:15870414 | pubmed:meshHeading | pubmed-meshheading:15870414... | lld:pubmed |
| pubmed-article:15870414 | pubmed:meshHeading | pubmed-meshheading:15870414... | lld:pubmed |
| pubmed-article:15870414 | pubmed:meshHeading | pubmed-meshheading:15870414... | lld:pubmed |
| pubmed-article:15870414 | pubmed:meshHeading | pubmed-meshheading:15870414... | lld:pubmed |
| pubmed-article:15870414 | pubmed:meshHeading | pubmed-meshheading:15870414... | lld:pubmed |
| pubmed-article:15870414 | pubmed:meshHeading | pubmed-meshheading:15870414... | lld:pubmed |
| pubmed-article:15870414 | pubmed:meshHeading | pubmed-meshheading:15870414... | lld:pubmed |
| pubmed-article:15870414 | pubmed:year | 2005 | lld:pubmed |
| pubmed-article:15870414 | pubmed:articleTitle | Tirofiban and sirolimus-eluting stent vs abciximab and bare-metal stent for acute myocardial infarction: a randomized trial. | lld:pubmed |
| pubmed-article:15870414 | pubmed:affiliation | Chair of Cardiology, University of Ferrara, Cardiovascular Institute, Arcispedale S. Anna, Italy. vlgmrc@unife.it | lld:pubmed |
| pubmed-article:15870414 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:15870414 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:15870414 | pubmed:publicationType | Comparative Study | lld:pubmed |
| pubmed-article:15870414 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
| pubmed-article:15870414 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15870414 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15870414 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15870414 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15870414 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15870414 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15870414 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15870414 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15870414 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15870414 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15870414 | lld:pubmed |
